Special Purpose Acquisition Companies (SPACs), largely dormant since 2022, have revived amid the new U.S. administration, under which a potentially more business-friendly Securities and Exchange Commission (SEC) and tariff uncertainties have caused companies to reconsider IPO plans.
Despite the reemergence of SPAC activity, core litigation risks persist. Directors and officers (D&O) insurance coverage is therefore essential for businesses going public via a SPAC IPO.
Litigation: The Persistent Shadow Over SPAC Evolution
SPACs flourished in 2021, raising more than $160 billion in capital. However, many post-deSPAC companies underperformed. In fact, by late 2023 more than 20 SPAC-backed firms had filed for bankruptcy, evaporating approximately $46 billion in equity value.1
The SPAC boom and bust prompted the SEC to pass new rules imposing heightened disclosure and procedural requirements applicable to SPAC IPOs and deSPAC transactions. It also encouraged a wave of shareholder and government enforcement in D&O actions.
The first eight months of 2025 saw 81 SPAC IPO filings in the U.S., raising $16.1 billion — up from just $1.8 billion in 2024.2 This year, SPACs have also accounted for approximately 60% of all IPO volume and 40% of total proceeds.3
Recurring issues, however, like regulatory uncertainty, complex deSPAC litigation and headline-making bankruptcies, remain significant obstacles for deals.
“SPACs are generally viewed as an easier and cheaper way for a company to go public,” says Adam Furmansky, D&O Product Leader – East for Aon’s Financial Services Group in the United States. “But, they’re not simply a shortcut to public capital. SPACs are financial vehicles operating under a spotlight — each step in the process is now more likely to be scrutinized by the market, and if that scrutiny does not pass muster, tested in the courts.”
What’s Driving SPAC and DeSPAC Litigation Concerns?
SPAC litigation typically falls into three categories:
- SPAC IPO litigation (currently uncommon)
- Litigation challenging the deSPAC transaction
- Post-deSPAC litigation, similar to traditional securities class action stock drop litigation, with claims of inadequate or inaccurate disclosure, or underperformance
The second and third types are the most common. In addition to underlying litigation, coverage disputes regarding deSPAC transactions are a potential challenge, with post-transaction claims being particularly complex. Most post-transaction litigation is filed in federal court and comes with significant defense costs or sizable settlement amounts that may be in the tens of millions of dollars or higher.